Skip to main content
. 2017 Jan-Feb;43(1):5. doi: 10.1590/S1806-37562017000000021

Table 1. Types of outcomes.

Outcome Patient-centered Composite Surrogate
Asthma Asthma control (questionnaire) Hospitalization or a > 20% decline in asthma control FEV1, peak flow, eosinophils
PAH 2-year survival Lung transplantation or death 6MWD, PASP
ARDS Hospital survival Time to extubation or tracheotomy PaO2/FiO2 ratio, ventilator-free days

PAH: pulmonary arterial hypertension; 6MWD: six-minute walk distance; and PASP: pulmonary artery systolic pressure.